|Systematic (IUPAC) name|
|CAS Registry Number|
|Molecular mass||359.47 g/mol|
Lavoltidine (INN, USAN, BAN; code name AH-23,844), previously known as loxtidine, is a highly potent and selective H2 receptor antagonist which was under development as a treatment for gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid tumors in rodents.
- H2 receptor antagonist
- Sufotidine (analogous sequence in which sulfone replaces the hydroxyl group).